There's the 13p - only took a few hours
Crazy cheap when you look at the market cap, hopefully the TR1's are picking up the cheap stock, back to 15p would be nice and without the seller I suspect we would have been trading about 17-18p today
MCAP even at 13p is only £2.5m, could easily be another 50-100% from here
Win or lose really happy with the price, got lucky I bought these at 11.5p earlier in the year and sold for a quick buck as needed the cash, but at the time I was gutted I didn't get the lows of 8-9p, the seller has now given that chance back however ofc unsure why they are selling but I feel it could just be a reshuffle since they did change management back in Nov 2021, so always the risk of movement, didn't expect them to smash the bid so much but maybe £230K is buttons and wanted to take advantage elsewhere, still almost a 50% loss at the bid vs ask few days back
Would make sense
Market is only giving it £40m value, yet the holding in Block is currently worth 618,750 x $128 = $79.2m USD, converted to GBP ~58.56m
They already have £7 cash in the bank, so current cash equivalents of £65m, or approx. 65% higher than our current share price (~62p per share) so they could easily sell some shares and do a dividend IF the market keeps them under 40p
Not bad reading
Market cap £15m (2.9p)
Cash £11.2m
Loss £8m
Revenues for the upcoming period £3.1m (Subway, Bitstamp, HyperX, Samsung)
Profit on Revenue in 2021 ~50% (after cost of sales)
Profit on current 2022 rev likely to be around ~£1.5m
IPO document earmarked £12m for 2021 with £8m for 2022, so not too bad we have £11.2m ready to deploy to grow the brand further
Competitor Value at £15m
On board £3.1m in revenues (sponsors) and £11.2m cash , therefore a competitor could purchase GILD pretty much for free at the current market cap, it wont happen of course but in theory
If they IPO'd today with £11.2m in cash and Subway/Bit stamp sponsors I suspect it would be way north of £20m+
Have to reset to current conditions
Lots to do and more sponsors needed, but at £15m MCAP likely the best value e-sports organisation in the world so pretty happy to be adding here
not advice and good luck
Sorry I didn't finish that sentence and it may come across a bit rude so apologies
What I am saying is, the MM's control the price action (bid/ask) so they are simply taking advantage of the sellers, as they know anyone selling here is taking a huge loss, why stocks like this get caught in a downward trend, I think people call it 'walking it down' - I always though it was a load of rubbish but it true, when sentiment is shot and there isn't a large background buyer, its so easy to walk stocks down
Zoom if you buy a house for £100K and sell it for £80K there has been one buy and one sell, yet the value has dropped by £20K
If someone then buys it for £90K, then the number of buys outweigh the number of sells 2-1 yet the price is down 10%
Yes I am still here, added a bit more at 16.5p, willing to go down with the ship now
Will be in high demand come Summer
General feel is people are not interested in a fourth dose
Also caution to the wind with the new variant, look around you
So when the fourth dose a come callin', I suspect ABDX will see some demand for the antibody tests
Theory
Asset value probably around £12m here, £8.9m invested since 2020 - add on cash maybe an extra £5m... so £17m in assets, if the DHSC ever comes in would be about £23-24m.. more than current market cap just on machines and cash
valued at less than machines and cash, got to laugh
GDR MCAP £19m pitiful revenues no assets and one play on a POC device, albeit could be a good device but has the covid revs now dried up for small players, near zero sales of any covid products since pandemic began
ODX MCAP £25m again few sales but do have a decent test with Mologic, potential 2.5m refund to govt would leave them with no cash - why has the test not sold to date, partnership with DAM health could provide some revs and upside but cash fears and current sell off plus CEO and NED leaving the team/ship more red flags
ABDX £22m mcap two antigen tests two/three antibody tests, asset base worth about £10m (PP&E) plus just raised £6.5m cash and potentially owed £8m from DHSC if they ever pay - if paid assets would outweight market cap, capacity of 80m PA foiled devices should diagnostics take off next couple of years
Quick snippet of each there missing out probably lots of key details but make your own mind up